Numerical modelling of the perturbation of HIV-1 during combination anti-retroviral therapy

A competitive, chaos-free, implicit, finite-difference method is developed and used for a novel deterministic model for the perturbation of HIV by combination antiretroviral therapy. The compartmental model monitors the interaction between HIV and CD4(+) T cells, its principal target and site of replication in vivo, in the presence of reverse transcription inhibitors and protease inhibitors. The model exhibits two steady states, an uninfected (trivial) steady state (with no virus present) and an endemically infected state (with virus and infected T cells present). Stability and bifurcation analyses together with numerical simulations of the resulting dynamical system are reported.

[1]  Hana Golding,et al.  Coreceptor Competition for Association with CD4 May Change the Susceptibility of Human Cells to Infection with T-Tropic and Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.

[2]  G Carosi,et al.  HIV-1 pharmacoresistance: clinical and therapeutic implications. , 1999, Journal of biological regulators and homeostatic agents.

[3]  S. Frost,et al.  Germinal centre destruction as a major pathway of HIV pathogenesis. , 1994, Journal of acquired immune deficiency syndromes.

[4]  L J Davis,et al.  Active human immunodeficiency virus protease is required for viral infectivity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Broder,et al.  Chemokine receptors and HIV , 1997, Journal of leukocyte biology.

[6]  M. Bukrinsky,et al.  Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. , 2000, Journal of molecular biology.

[7]  S D Kemp,et al.  Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). , 1989, Science.

[8]  B. Larder,et al.  Viral resistance and the selection of antiretroviral combinations. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[9]  M A Nowak,et al.  Models of interactions between HIV and other pathogens. , 1992, Journal of theoretical biology.

[10]  D. Ho,et al.  Toward HIV eradication or remission: the tasks ahead. , 1998, Science.

[11]  P. Holmes,et al.  Nonlinear Oscillations, Dynamical Systems, and Bifurcations of Vector Fields , 1983, Applied Mathematical Sciences.

[12]  E. De Clercq,et al.  Anti-Human Immunodeficiency Virus Drug Combination Strategies , 1998, Antiviral chemistry & chemotherapy.

[13]  P. Y.,et al.  ANALYSIS OF NON-LINEAR DYNAMICS AND BIFURCATIONS OF A DOUBLE PENDULUM , 1998 .

[14]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[15]  E. De Clercq,et al.  Antiviral therapy for human immunodeficiency virus infections , 1995, Clinical microbiology reviews.

[16]  A S Perelson,et al.  Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads. , 1998, Journal of theoretical biology.

[17]  G. F. Webb,et al.  Understanding drug resistance for monotherapy treatment of HIV infection , 1997, Bulletin of mathematical biology.

[18]  R D MacArthur,et al.  Treatment of HIV disease in the new millennium. , 2000, Seminars in thoracic and cardiovascular surgery.

[19]  R. Silverman,et al.  Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. , 1990, Journal of experimental pathology.

[20]  Denise E. Kirschner,et al.  Using Mathematics to Understand HIV Immune Dynamics , 1997 .

[21]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[22]  A S Perelson,et al.  Dynamics of HIV-1 and CD4+ lymphocytes in vivo. , 1997, AIDS.

[23]  R M May,et al.  Epidemiological parameters of HIV transmission. , 1988, Nature.

[24]  J. Karn,et al.  Control of human immunodeficiency virus replication by the tat, rev, nef and protease genes. , 1991, Current opinion in immunology.

[25]  G. Pavlakis,et al.  Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs , 1992, Molecular and cellular biology.

[26]  Mark Harrington,et al.  Hit HIV-1 hard, but only when necessary , 2000, The Lancet.

[27]  E. H. Twizell.  Numerical Methods, with Applications in the Biomedical Sciences , 1988 .

[28]  Angela R. McLean,et al.  Zidovudine and HIV: Mathematical models of within‐host population dynamics , 1995 .

[29]  D. Kirschner,et al.  A model for treatment strategy in the chemotherapy of AIDS. , 1996, Bulletin of mathematical biology.

[30]  S. Frost,et al.  Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection , 1994, AIDS.

[31]  J. Lambert.  Numerical Methods for Ordinary Differential Systems: The Initial Value Problem , 1991 .

[32]  J. Yin,et al.  Quantitative intracellular kinetics of HIV type 1. , 1999, AIDS research and human retroviruses.

[33]  William C. Olson,et al.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.

[34]  A. Booth.  Numerical Methods , 1957, Nature.

[35]  E. Asante-Appiah,et al.  Molecular mechanisms in retrovirus DNA integration. , 1997, Antiviral research.

[36]  Åke Björck,et al.  Numerical Methods , 1995, Handbook of Marine Craft Hydrodynamics and Motion Control.

[37]  C Stone,et al.  Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group. , 2000, The Journal of infectious diseases.

[38]  D. Kabat,et al.  Roles of CD4 and Coreceptors in Binding, Endocytosis, and Proteolysis of gp120 Envelope Glycoproteins Derived from Human Immunodeficiency Virus Type 1* , 1999, The Journal of Biological Chemistry.

[39]  D. Kirschner,et al.  Optimal control of the chemotherapy of HIV , 1997, Journal of mathematical biology.

[40]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[41]  D. Purcell,et al.  Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity , 1993, Journal of virology.

[42]  Alan S. Perelson,et al.  Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.

[43]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[44]  M A Wainberg,et al.  The role and fate of the CD4 molecule in lymphocytes and monocytes infected by HIV-1. , 1993, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[45]  Lawrence M. Wein,et al.  Mathematical considerations of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads , 1997 .

[46]  D. Richman,et al.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. , 1989, Science.